CDMRP: Breast Cancer (BC) Research Program – Pre-proposals
שם: |
CDMRP: Breast Cancer (BC) Research Program – Pre-proposals
תאריך הגשה: 28/04/22 לאתר הקול הקורא |
תיאור כללי: |
Overarching Challenges
- Prevent breast cancer (primary prevention)
- Identify determinants of breast cancer initiation, risk, or susceptibility
- Distinguish deadly from non-deadly breast cancers
- Conquer the problems of overdiagnosis and overtreatment
- Identify what drives breast cancer growth; determine how to stop it
- Identify why some breast cancers become metastatic
- Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence
- Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
- Eliminate the mortality associated with metastatic breast cancer
- Alternatively, with adequate justification, applications may identify and address another overarching challenge"
Funding mechanisms:
- Breakthrough Awards: Supports promising research that has high potential make breakthroughs in BC (may be near-term or long-term). $450K - $10M, depending on the specific program.
- Era of Hope Scholar Award: Supports individuals early in their careers (within 6 years of their last training position) who have demonstrated significant potential to effect meaningful change in BC. Up to $3M for 4 years.
- Innovator Award: Supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to BC. Provides these individuals with the opportunity and freedom to pursue visionary, high-risk ideas that could accelerate progress toward ending BC. Up to $7M for 4 years.
- Transformative BC Consortium Award: Supports collaborations and ideas that will improve the lives of individuals with, and/or at risk for, BC and will significantly accelerate progress toward ending breast cancer. Requires a synergistic, highly integrated, multidisciplinary, and multi-institutional research team of leading scientists, clinicians, and consumer advocates who will be assembled into a consortium to address a major problem in a way that could not be accomplished by a single investigator or group. The consortium should have at least 4, but no more than 5 project teams, each investigating different projects under a central hypothesis. Up to $25M for 4 years
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=413101
https://ebrap.org/eBRAP/public/ViewFileTemplate.htm?fileTemplateId=10063236&fileType=pdf
|
מקור: |
זר
|
מס' שנים למחקר: |
3-4
|
איש קשר: |
Robi, 2152, robertg@trdf.technion.ac.il; iris 1272, irisbr@campus.technion.ac.il
|
תחומים: |
מדעי החיים ורפואה
|
סוג הקרן: |
הקרן אינה קרן תחרותית.
|
קרן ופרופילים משויכים: |
Congressionally Directed Medical Research Programs - CDMRP ,פתוח לחברי סגל הטכניון בלבד. אנא התחבר\י כדי לצפות בפרופילי המימון של הקרן (בפינה הימנית העליונה). |